← Open Payments lookup

KIMBERLY MEIXNER: Open Payments

NPI 1154545291 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$454 in 13 payments from 7 companies in 2025. Trend: 2023 $903 · 2024 $271 · 2025 $454

Food & beverage: $454
CompanyPaymentsAmount
Adaptive Biotechnologies Corporation2$169
Novartis Pharmaceuticals Corporation3$86
Regeneron Healthcare Solutions, Inc.3$76
Bayer Healthcare Pharmaceuticals Inc.2$55
Daiichi Sankyo Inc.1$28
Merck Sharp & Dohme LLC1$22
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: clonoSEQ, PLUVICTO, LIBTAYO, Nubeqa, Enhertu, Xofigo, KEYTRUDA, FRUZAQLA.

Industry payments across TX — which companies pay providers there.